Jin-Hua Sun

2.6k total citations · 1 hit paper
34 papers, 2.0k citations indexed

About

Jin-Hua Sun is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jin-Hua Sun has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 13 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Jin-Hua Sun's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (10 papers) and HIV/AIDS drug development and treatment (9 papers). Jin-Hua Sun is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (10 papers) and HIV/AIDS drug development and treatment (9 papers). Jin-Hua Sun collaborates with scholars based in United States, Germany and China. Jin-Hua Sun's co-authors include Donald R. O’Boyle, Robert A. Fridell, Chunfu Wang, Julie A. Lemm, Peter T. Nower, Nicholas A. Meanwell, Richard E. Nettles, Lawrence B. Snyder, Richard J. Colonno and Chia‐Sui Kao and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Jin-Hua Sun

33 papers receiving 1.9k citations

Hit Papers

Chemical genetics strategy identifies an HCV NS5A inhibit... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin-Hua Sun United States 24 1.3k 1.0k 607 427 183 34 2.0k
Julie A. Lemm United States 22 1.3k 1.0× 1.1k 1.1× 1.0k 1.7× 477 1.1× 121 0.7× 33 2.4k
Kai Lin United States 25 1.0k 0.8× 919 0.9× 588 1.0× 579 1.4× 36 0.2× 50 2.0k
Nanhua Yao United States 23 953 0.7× 613 0.6× 524 0.9× 866 2.0× 81 0.4× 40 2.2k
Angela M. Lam United States 27 1.5k 1.2× 1.4k 1.4× 1.1k 1.8× 913 2.1× 47 0.3× 61 2.7k
D R Averett United States 30 1.0k 0.8× 1.5k 1.5× 888 1.5× 735 1.7× 85 0.5× 56 2.8k
Robert Hamatake United States 33 765 0.6× 955 1.0× 593 1.0× 1.6k 3.7× 158 0.9× 76 3.1k
Kenneth Simmen Belgium 20 753 0.6× 892 0.9× 459 0.8× 450 1.1× 34 0.2× 39 1.6k
David Tyrrell Canada 20 1.3k 1.0× 1.4k 1.4× 549 0.9× 517 1.2× 98 0.5× 47 2.3k
Tsuyoshi Adachi Japan 12 694 0.5× 406 0.4× 305 0.5× 370 0.9× 38 0.2× 20 1.2k
Sophie Le Pogam United States 25 1.4k 1.1× 1.2k 1.1× 921 1.5× 497 1.2× 17 0.1× 50 2.0k

Countries citing papers authored by Jin-Hua Sun

Since Specialization
Citations

This map shows the geographic impact of Jin-Hua Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-Hua Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-Hua Sun more than expected).

Fields of papers citing papers by Jin-Hua Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-Hua Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-Hua Sun. The network helps show where Jin-Hua Sun may publish in the future.

Co-authorship network of co-authors of Jin-Hua Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-Hua Sun. A scholar is included among the top collaborators of Jin-Hua Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-Hua Sun. Jin-Hua Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Hong, et al.. (2025). Multifunctional PDMS/Fe₃O₄@MMT/SA@PDA-modified melamine sponge for oil/water separation and fire suppression. Colloids and Surfaces A Physicochemical and Engineering Aspects. 728. 138515–138515.
2.
Fang, Zheng, Qiangling Duan, Qingkui Peng, et al.. (2023). A sustainable delamination method to completely separate spent cathode foils via biomass-derived γ-valerolactone. Green Chemistry. 25(4). 1546–1558. 11 indexed citations
3.
Chen, Zhaojun, Liquan Hong, Feng Pan, et al.. (2016). miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. OncoTargets and Therapy. 9. 2639–2639. 34 indexed citations
4.
Wang, Chunfu, Lingling Jia, Donald R. O’Boyle, et al.. (2014). Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity. Antimicrobial Agents and Chemotherapy. 58(9). 5155–5163. 54 indexed citations
5.
O’Boyle, Donald R., Jin-Hua Sun, Peter T. Nower, et al.. (2013). Characterizations of HCV NS5A replication complex inhibitors. Virology. 444(1-2). 343–354. 35 indexed citations
6.
Gao, Min, Donald R. O’Boyle, Julie A. Lemm, et al.. (2013). 1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO. Journal of Hepatology. 58. S573–S574. 3 indexed citations
7.
Wang, Chunfu, Jin-Hua Sun, Donald R. O’Boyle, et al.. (2013). Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy. 57(5). 2054–2065. 80 indexed citations
8.
Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations
9.
Sun, Jin-Hua, Donald R. O’Boyle, Yan Zhang, et al.. (2012). Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052. Hepatology. 55(6). 1692–1699. 41 indexed citations
10.
Lemm, Julie A., John E. Leet, Donald R. O’Boyle, et al.. (2011). Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures. Antimicrobial Agents and Chemotherapy. 55(8). 3795–3802. 38 indexed citations
11.
Qiu, Dike, Julie A. Lemm, Donald R. O’Boyle, et al.. (2011). The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization. Journal of General Virology. 92(11). 2502–2511. 44 indexed citations
12.
Gao, Min, Richard E. Nettles, Makonen Belema, et al.. (2010). Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature. 465(7294). 96–100. 689 indexed citations breakdown →
14.
Miller, Kathy D., Susan M. Perkins, Jin-Hua Sun, et al.. (2009). A pilot study of vascular endothelial growth factor inhibition with bevacizumab in patients with lymphedema following breast cancer treatment. Journal of Clinical Oncology. 27(15_suppl). 9523–9523. 1 indexed citations
15.
Wang, Ying-Kai, Karen Rigat, Jin-Hua Sun, Min Gao, & Susan B. Roberts. (2007). RNA template-mediated inhibition of hepatitis C virus RNA-dependent RNA polymerase activity. Archives of Biochemistry and Biophysics. 470(2). 146–152. 7 indexed citations
16.
Sun, Jin-Hua & C. Cheng Kao. (1997). RNA Synthesis by the Brome Mosaic Virus RNA-Dependent RNA Polymerase: Transition from Initiation to Elongation. Virology. 233(1). 63–73. 34 indexed citations
17.
Sun, Jin-Hua & C. Cheng Kao. (1997). Characterization of RNA Products Associated with or Aborted by a Viral RNA-Dependent RNA Polymerase. Virology. 236(2). 348–353. 31 indexed citations
18.
19.
Sun, Jin-Hua & C. Cheng Kao. (1995). Double-Stranded RNA Is Nonspecifically Bound by Agarose. Analytical Biochemistry. 230(1). 185–187. 4 indexed citations
20.
Cobb, Patrick, Donna Degen, Gary M. Clark, et al.. (1994). Activity of DMP 840, a New Bis-naphthalimide, on Primary Human Tumor Colony-Forming Units. JNCI Journal of the National Cancer Institute. 86(19). 1462–1465. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026